 CVD Equipment Corporation NASDAQ: CVV today announced that its subsidiary, CVD Materials Corporation CVDM, will together with Dymax Corporation and Keyence Corporation of America collaborate in an effort to accelerate the development of CVDMs novel c-VACNTTM Extracorporeal Membrane Oxygenation ECMO platform. ECMO devices are used to add Oxygen and remove Carbon Dioxide from a blood stream during periods when the patients lungs are not performing at appropriate levels. Typically, they are used during heart lung surgery, but have recently been used as a last resort for recovery from COVID-19 illness. 